Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
271 |
|
Actual shortage: | 7 (3%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 14 (5%) | |
Resolved: | 250 (92%) | |
Discontinuation Reports |
49 |
|
To be discontinued: | 5 (10%) | |
Discontinued: | 44 (90%) | |
Reversed: | 0 (0%) | |
Late reports |
20 (6%) |
|
Overdue reports |
4 (33%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MERSYNDOL WITH CODEINE | 325MG 5MG 8MG | TABLET | Resolved | 2023-05-05 | 2023-07-10 | 191773 |
MOZOBIL | 20MG | SOLUTION | Resolved | 2020-06-19 | 2020-06-26 | 118345 |
MOZOBIL | 20MG | SOLUTION | Avoided shortage | 2020-09-25 | 2020-11-25 | 125088 |
MULTAQ | 400MG | TABLET | Resolved | 2018-12-10 | 2019-02-06 | 68993 |
MULTAQ | 400MG | TABLET | Resolved | 2021-07-23 | 2021-11-17 | 142946 |
MULTAQ | 400MG | TABLET | Actual shortage | 2024-03-13 | 2024-04-18 | 222061 |
MYOCHRYSINE | 50MG | SOLUTION | Resolved | 2017-11-15 | 2019-06-10 | 29274 |
MYOCHRYSINE | 25MG | SOLUTION | Resolved | 2017-11-15 | 2019-06-10 | 29269 |
MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2017-07-06 | 2017-08-04 | 14864 |
MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-02-09 | 2018-03-05 | 39185 |
MYOCHRYSINE | 10MG | SOLUTION | Resolved | 2018-04-10 | 2019-06-10 | 45370 |
NALCROM | 100MG | CAPSULE | Resolved | 2019-04-03 | 2019-06-26 | 80347 |
NALCROM | 100MG | CAPSULE | Resolved | 2019-08-05 | 2019-08-24 | 90722 |
NALCROM | 100MG | CAPSULE | Resolved | 2020-10-15 | 2020-11-25 | 126537 |
NALCROM | 100MG | CAPSULE | Resolved | 2021-03-02 | 2021-05-22 | 134957 |
NALCROM | 100MG | CAPSULE | Resolved | 2022-03-22 | 2022-03-28 | 157078 |
NALCROM | 100MG | CAPSULE | Resolved | 2022-04-14 | 2022-05-04 | 158887 |
NALCROM | 100MG | CAPSULE | Resolved | 2022-06-20 | 2022-09-24 | 163129 |
NALCROM | 100MG | CAPSULE | Resolved | 2022-10-13 | 2023-07-01 | 171702 |
NALCROM | 100MG | CAPSULE | Actual shortage | 2024-02-22 | 2024-03-07 | 220296 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98371 |
NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |
RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |